nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftriaxone—ALB—Vandetanib—thyroid cancer	0.0933	1	CbGbCtD
Ceftriaxone—Glossodynia—Sorafenib—thyroid cancer	0.0276	0.031	CcSEcCtD
Ceftriaxone—Serum creatinine increased—Vandetanib—thyroid cancer	0.0222	0.0249	CcSEcCtD
Ceftriaxone—Cholelithiasis—Vandetanib—thyroid cancer	0.0219	0.0247	CcSEcCtD
Ceftriaxone—Lymphopenia—Sorafenib—thyroid cancer	0.018	0.0202	CcSEcCtD
Ceftriaxone—Fungal infection—Vandetanib—thyroid cancer	0.0177	0.0199	CcSEcCtD
Ceftriaxone—Nephrolithiasis—Vandetanib—thyroid cancer	0.017	0.0191	CcSEcCtD
Ceftriaxone—Proteinuria—Vandetanib—thyroid cancer	0.0155	0.0175	CcSEcCtD
Ceftriaxone—Protein urine present—Vandetanib—thyroid cancer	0.0153	0.0172	CcSEcCtD
Ceftriaxone—Colitis—Vandetanib—thyroid cancer	0.0131	0.0147	CcSEcCtD
Ceftriaxone—Secondary infection—Epirubicin—thyroid cancer	0.0116	0.013	CcSEcCtD
Ceftriaxone—Secondary infection—Doxorubicin—thyroid cancer	0.0107	0.012	CcSEcCtD
Ceftriaxone—Warmth—Epirubicin—thyroid cancer	0.0107	0.012	CcSEcCtD
Ceftriaxone—Proteinuria—Sorafenib—thyroid cancer	0.0105	0.0118	CcSEcCtD
Ceftriaxone—Protein urine present—Sorafenib—thyroid cancer	0.0103	0.0116	CcSEcCtD
Ceftriaxone—Glossitis—Sorafenib—thyroid cancer	0.00999	0.0112	CcSEcCtD
Ceftriaxone—Drug interaction—Sorafenib—thyroid cancer	0.00992	0.0112	CcSEcCtD
Ceftriaxone—Warmth—Doxorubicin—thyroid cancer	0.0099	0.0111	CcSEcCtD
Ceftriaxone—Blood creatinine increased—Vandetanib—thyroid cancer	0.00928	0.0104	CcSEcCtD
Ceftriaxone—Bronchospasm—Vandetanib—thyroid cancer	0.00842	0.00947	CcSEcCtD
Ceftriaxone—Pancreatitis—Vandetanib—thyroid cancer	0.00839	0.00944	CcSEcCtD
Ceftriaxone—Neutropenia—Vandetanib—thyroid cancer	0.00801	0.009	CcSEcCtD
Ceftriaxone—Hepatic function abnormal—Sorafenib—thyroid cancer	0.00765	0.0086	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Vandetanib—thyroid cancer	0.00757	0.00851	CcSEcCtD
Ceftriaxone—Renal failure—Vandetanib—thyroid cancer	0.0075	0.00844	CcSEcCtD
Ceftriaxone—Stomatitis—Vandetanib—thyroid cancer	0.00744	0.00837	CcSEcCtD
Ceftriaxone—Haematuria—Vandetanib—thyroid cancer	0.00728	0.00818	CcSEcCtD
Ceftriaxone—Epistaxis—Vandetanib—thyroid cancer	0.0072	0.0081	CcSEcCtD
Ceftriaxone—Dermatitis exfoliative—Sorafenib—thyroid cancer	0.00708	0.00796	CcSEcCtD
Ceftriaxone—Haemoglobin—Vandetanib—thyroid cancer	0.00689	0.00774	CcSEcCtD
Ceftriaxone—Haemorrhage—Vandetanib—thyroid cancer	0.00685	0.00771	CcSEcCtD
Ceftriaxone—Lactic dehydrogenase activity increased—Epirubicin—thyroid cancer	0.00665	0.00748	CcSEcCtD
Ceftriaxone—Lymphopenia—Epirubicin—thyroid cancer	0.00665	0.00748	CcSEcCtD
Ceftriaxone—Erythema multiforme—Vandetanib—thyroid cancer	0.00648	0.00729	CcSEcCtD
Ceftriaxone—Lactic dehydrogenase activity increased—Doxorubicin—thyroid cancer	0.00615	0.00692	CcSEcCtD
Ceftriaxone—Lymphopenia—Doxorubicin—thyroid cancer	0.00615	0.00692	CcSEcCtD
Ceftriaxone—Local reaction—Epirubicin—thyroid cancer	0.00615	0.00691	CcSEcCtD
Ceftriaxone—Abdominal pain upper—Sorafenib—thyroid cancer	0.0061	0.00686	CcSEcCtD
Ceftriaxone—Toxic epidermal necrolysis—Sorafenib—thyroid cancer	0.00602	0.00677	CcSEcCtD
Ceftriaxone—Aspartate aminotransferase increased—Sorafenib—thyroid cancer	0.00602	0.00677	CcSEcCtD
Ceftriaxone—Blood lactate dehydrogenase increased—Epirubicin—thyroid cancer	0.00585	0.00658	CcSEcCtD
Ceftriaxone—Dysgeusia—Vandetanib—thyroid cancer	0.00584	0.00657	CcSEcCtD
Ceftriaxone—Local reaction—Doxorubicin—thyroid cancer	0.00569	0.00639	CcSEcCtD
Ceftriaxone—Pancreatitis—Sorafenib—thyroid cancer	0.00566	0.00637	CcSEcCtD
Ceftriaxone—Serum creatinine increased—Epirubicin—thyroid cancer	0.00553	0.00622	CcSEcCtD
Ceftriaxone—Thrombocytosis—Epirubicin—thyroid cancer	0.00547	0.00615	CcSEcCtD
Ceftriaxone—Blood lactate dehydrogenase increased—Doxorubicin—thyroid cancer	0.00542	0.00609	CcSEcCtD
Ceftriaxone—Neutropenia—Sorafenib—thyroid cancer	0.0054	0.00607	CcSEcCtD
Ceftriaxone—Convulsion—Vandetanib—thyroid cancer	0.00517	0.00581	CcSEcCtD
Ceftriaxone—Serum creatinine increased—Doxorubicin—thyroid cancer	0.00512	0.00575	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Sorafenib—thyroid cancer	0.00511	0.00574	CcSEcCtD
Ceftriaxone—Thrombocytosis—Doxorubicin—thyroid cancer	0.00506	0.00569	CcSEcCtD
Ceftriaxone—Renal failure—Sorafenib—thyroid cancer	0.00506	0.00569	CcSEcCtD
Ceftriaxone—Stomatitis—Sorafenib—thyroid cancer	0.00502	0.00564	CcSEcCtD
Ceftriaxone—Jaundice—Sorafenib—thyroid cancer	0.00502	0.00564	CcSEcCtD
Ceftriaxone—Oedema—Vandetanib—thyroid cancer	0.00487	0.00547	CcSEcCtD
Ceftriaxone—Epistaxis—Sorafenib—thyroid cancer	0.00486	0.00546	CcSEcCtD
Ceftriaxone—Infection—Vandetanib—thyroid cancer	0.00484	0.00544	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Vandetanib—thyroid cancer	0.00477	0.00536	CcSEcCtD
Ceftriaxone—Haemoglobin—Sorafenib—thyroid cancer	0.00465	0.00522	CcSEcCtD
Ceftriaxone—Haemorrhage—Sorafenib—thyroid cancer	0.00462	0.0052	CcSEcCtD
Ceftriaxone—Dermatitis atopic—Epirubicin—thyroid cancer	0.0046	0.00517	CcSEcCtD
Ceftriaxone—Fungal infection—Epirubicin—thyroid cancer	0.00441	0.00495	CcSEcCtD
Ceftriaxone—Paraesthesia—Vandetanib—thyroid cancer	0.00437	0.00492	CcSEcCtD
Ceftriaxone—Erythema multiforme—Sorafenib—thyroid cancer	0.00437	0.00491	CcSEcCtD
Ceftriaxone—Feeling hot—Epirubicin—thyroid cancer	0.00433	0.00487	CcSEcCtD
Ceftriaxone—Flushing—Sorafenib—thyroid cancer	0.00429	0.00482	CcSEcCtD
Ceftriaxone—Dyspepsia—Vandetanib—thyroid cancer	0.00429	0.00482	CcSEcCtD
Ceftriaxone—Dermatitis atopic—Doxorubicin—thyroid cancer	0.00425	0.00478	CcSEcCtD
Ceftriaxone—Glycosuria—Epirubicin—thyroid cancer	0.0042	0.00472	CcSEcCtD
Ceftriaxone—Pain—Vandetanib—thyroid cancer	0.00416	0.00468	CcSEcCtD
Ceftriaxone—Fungal infection—Doxorubicin—thyroid cancer	0.00408	0.00458	CcSEcCtD
Ceftriaxone—Feeling hot—Doxorubicin—thyroid cancer	0.00401	0.00451	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00398	0.00448	CcSEcCtD
Ceftriaxone—Dysgeusia—Sorafenib—thyroid cancer	0.00394	0.00443	CcSEcCtD
Ceftriaxone—Glycosuria—Doxorubicin—thyroid cancer	0.00389	0.00437	CcSEcCtD
Ceftriaxone—Abdominal pain—Vandetanib—thyroid cancer	0.00385	0.00433	CcSEcCtD
Ceftriaxone—Body temperature increased—Vandetanib—thyroid cancer	0.00385	0.00433	CcSEcCtD
Ceftriaxone—Anaemia—Sorafenib—thyroid cancer	0.00372	0.00418	CcSEcCtD
Ceftriaxone—Oliguria—Epirubicin—thyroid cancer	0.00369	0.00415	CcSEcCtD
Ceftriaxone—Glossitis—Epirubicin—thyroid cancer	0.00369	0.00415	CcSEcCtD
Ceftriaxone—Leukopenia—Sorafenib—thyroid cancer	0.0036	0.00405	CcSEcCtD
Ceftriaxone—Pruritus—Vandetanib—thyroid cancer	0.00344	0.00387	CcSEcCtD
Ceftriaxone—Glossitis—Doxorubicin—thyroid cancer	0.00342	0.00384	CcSEcCtD
Ceftriaxone—Oliguria—Doxorubicin—thyroid cancer	0.00342	0.00384	CcSEcCtD
Ceftriaxone—Vaginal inflammation—Epirubicin—thyroid cancer	0.0034	0.00383	CcSEcCtD
Ceftriaxone—Diarrhoea—Vandetanib—thyroid cancer	0.00333	0.00375	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Sorafenib—thyroid cancer	0.00328	0.00369	CcSEcCtD
Ceftriaxone—Colitis—Epirubicin—thyroid cancer	0.00327	0.00367	CcSEcCtD
Ceftriaxone—Infection—Sorafenib—thyroid cancer	0.00326	0.00367	CcSEcCtD
Ceftriaxone—Candida infection—Epirubicin—thyroid cancer	0.00325	0.00365	CcSEcCtD
Ceftriaxone—GLUL—neck—thyroid cancer	0.00323	0.187	CbGeAlD
Ceftriaxone—Dizziness—Vandetanib—thyroid cancer	0.00322	0.00362	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Sorafenib—thyroid cancer	0.00322	0.00362	CcSEcCtD
Ceftriaxone—Vaginal infection—Epirubicin—thyroid cancer	0.00321	0.00361	CcSEcCtD
Ceftriaxone—Aplastic anaemia—Epirubicin—thyroid cancer	0.00319	0.00359	CcSEcCtD
Ceftriaxone—Vaginal inflammation—Doxorubicin—thyroid cancer	0.00315	0.00354	CcSEcCtD
Ceftriaxone—Vomiting—Vandetanib—thyroid cancer	0.0031	0.00348	CcSEcCtD
Ceftriaxone—Rash—Vandetanib—thyroid cancer	0.00307	0.00345	CcSEcCtD
Ceftriaxone—Dermatitis—Vandetanib—thyroid cancer	0.00307	0.00345	CcSEcCtD
Ceftriaxone—Headache—Vandetanib—thyroid cancer	0.00305	0.00343	CcSEcCtD
Ceftriaxone—Colitis—Doxorubicin—thyroid cancer	0.00302	0.0034	CcSEcCtD
Ceftriaxone—Candida infection—Doxorubicin—thyroid cancer	0.00301	0.00338	CcSEcCtD
Ceftriaxone—Hypertonia—Epirubicin—thyroid cancer	0.00298	0.00335	CcSEcCtD
Ceftriaxone—Vaginal infection—Doxorubicin—thyroid cancer	0.00297	0.00334	CcSEcCtD
Ceftriaxone—Aplastic anaemia—Doxorubicin—thyroid cancer	0.00296	0.00332	CcSEcCtD
Ceftriaxone—Nausea—Vandetanib—thyroid cancer	0.00289	0.00325	CcSEcCtD
Ceftriaxone—Dyspepsia—Sorafenib—thyroid cancer	0.00289	0.00325	CcSEcCtD
Ceftriaxone—Phlebitis—Epirubicin—thyroid cancer	0.00287	0.00322	CcSEcCtD
Ceftriaxone—Thrombophlebitis—Epirubicin—thyroid cancer	0.00285	0.00321	CcSEcCtD
Ceftriaxone—Hepatic function abnormal—Epirubicin—thyroid cancer	0.00283	0.00318	CcSEcCtD
Ceftriaxone—Pain—Sorafenib—thyroid cancer	0.00281	0.00316	CcSEcCtD
Ceftriaxone—Hypertonia—Doxorubicin—thyroid cancer	0.00276	0.0031	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00269	0.00302	CcSEcCtD
Ceftriaxone—Phlebitis—Doxorubicin—thyroid cancer	0.00265	0.00298	CcSEcCtD
Ceftriaxone—Thrombophlebitis—Doxorubicin—thyroid cancer	0.00264	0.00297	CcSEcCtD
Ceftriaxone—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.00262	0.00294	CcSEcCtD
Ceftriaxone—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.00261	0.00294	CcSEcCtD
Ceftriaxone—Urticaria—Sorafenib—thyroid cancer	0.00261	0.00293	CcSEcCtD
Ceftriaxone—Abdominal pain—Sorafenib—thyroid cancer	0.0026	0.00292	CcSEcCtD
Ceftriaxone—Body temperature increased—Sorafenib—thyroid cancer	0.0026	0.00292	CcSEcCtD
Ceftriaxone—Renal impairment—Epirubicin—thyroid cancer	0.0026	0.00292	CcSEcCtD
Ceftriaxone—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.00255	0.00287	CcSEcCtD
Ceftriaxone—GLUL—saliva-secreting gland—thyroid cancer	0.00252	0.146	CbGeAlD
Ceftriaxone—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.00242	0.00272	CcSEcCtD
Ceftriaxone—Hypersensitivity—Sorafenib—thyroid cancer	0.00242	0.00272	CcSEcCtD
Ceftriaxone—Renal impairment—Doxorubicin—thyroid cancer	0.0024	0.0027	CcSEcCtD
Ceftriaxone—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.00236	0.00265	CcSEcCtD
Ceftriaxone—Pruritus—Sorafenib—thyroid cancer	0.00232	0.00261	CcSEcCtD
Ceftriaxone—Ataxia—Epirubicin—thyroid cancer	0.00232	0.00261	CcSEcCtD
Ceftriaxone—Blood creatinine increased—Epirubicin—thyroid cancer	0.00231	0.0026	CcSEcCtD
Ceftriaxone—Abdominal pain upper—Epirubicin—thyroid cancer	0.00226	0.00254	CcSEcCtD
Ceftriaxone—Diarrhoea—Sorafenib—thyroid cancer	0.00225	0.00253	CcSEcCtD
Ceftriaxone—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.00222	0.0025	CcSEcCtD
Ceftriaxone—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.00222	0.0025	CcSEcCtD
Ceftriaxone—Dizziness—Sorafenib—thyroid cancer	0.00217	0.00244	CcSEcCtD
Ceftriaxone—Ataxia—Doxorubicin—thyroid cancer	0.00215	0.00242	CcSEcCtD
Ceftriaxone—Blood creatinine increased—Doxorubicin—thyroid cancer	0.00214	0.00241	CcSEcCtD
Ceftriaxone—Eosinophilia—Epirubicin—thyroid cancer	0.00211	0.00238	CcSEcCtD
Ceftriaxone—Pancreatitis—Epirubicin—thyroid cancer	0.00209	0.00235	CcSEcCtD
Ceftriaxone—Vomiting—Sorafenib—thyroid cancer	0.00209	0.00235	CcSEcCtD
Ceftriaxone—Abdominal pain upper—Doxorubicin—thyroid cancer	0.00209	0.00235	CcSEcCtD
Ceftriaxone—Rash—Sorafenib—thyroid cancer	0.00207	0.00233	CcSEcCtD
Ceftriaxone—Dermatitis—Sorafenib—thyroid cancer	0.00207	0.00233	CcSEcCtD
Ceftriaxone—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.00206	0.00231	CcSEcCtD
Ceftriaxone—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.00206	0.00231	CcSEcCtD
Ceftriaxone—Headache—Sorafenib—thyroid cancer	0.00206	0.00231	CcSEcCtD
Ceftriaxone—Neutropenia—Epirubicin—thyroid cancer	0.002	0.00224	CcSEcCtD
Ceftriaxone—Eosinophilia—Doxorubicin—thyroid cancer	0.00196	0.0022	CcSEcCtD
Ceftriaxone—Nausea—Sorafenib—thyroid cancer	0.00195	0.00219	CcSEcCtD
Ceftriaxone—GLUL—trachea—thyroid cancer	0.00194	0.113	CbGeAlD
Ceftriaxone—Pancreatitis—Doxorubicin—thyroid cancer	0.00194	0.00218	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.00189	0.00212	CcSEcCtD
Ceftriaxone—Renal failure—Epirubicin—thyroid cancer	0.00187	0.0021	CcSEcCtD
Ceftriaxone—Stomatitis—Epirubicin—thyroid cancer	0.00186	0.00209	CcSEcCtD
Ceftriaxone—Jaundice—Epirubicin—thyroid cancer	0.00186	0.00209	CcSEcCtD
Ceftriaxone—Neutropenia—Doxorubicin—thyroid cancer	0.00185	0.00208	CcSEcCtD
Ceftriaxone—Haematuria—Epirubicin—thyroid cancer	0.00181	0.00204	CcSEcCtD
Ceftriaxone—Epistaxis—Epirubicin—thyroid cancer	0.0018	0.00202	CcSEcCtD
Ceftriaxone—Agranulocytosis—Epirubicin—thyroid cancer	0.00178	0.002	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.00175	0.00196	CcSEcCtD
Ceftriaxone—Renal failure—Doxorubicin—thyroid cancer	0.00173	0.00195	CcSEcCtD
Ceftriaxone—Haemoglobin—Epirubicin—thyroid cancer	0.00172	0.00193	CcSEcCtD
Ceftriaxone—Stomatitis—Doxorubicin—thyroid cancer	0.00172	0.00193	CcSEcCtD
Ceftriaxone—Jaundice—Doxorubicin—thyroid cancer	0.00172	0.00193	CcSEcCtD
Ceftriaxone—Haemorrhage—Epirubicin—thyroid cancer	0.00171	0.00192	CcSEcCtD
Ceftriaxone—Haematuria—Doxorubicin—thyroid cancer	0.00168	0.00189	CcSEcCtD
Ceftriaxone—Epistaxis—Doxorubicin—thyroid cancer	0.00166	0.00187	CcSEcCtD
Ceftriaxone—Agranulocytosis—Doxorubicin—thyroid cancer	0.00164	0.00185	CcSEcCtD
Ceftriaxone—Erythema multiforme—Epirubicin—thyroid cancer	0.00162	0.00182	CcSEcCtD
Ceftriaxone—Haemoglobin—Doxorubicin—thyroid cancer	0.00159	0.00179	CcSEcCtD
Ceftriaxone—Flushing—Epirubicin—thyroid cancer	0.00159	0.00178	CcSEcCtD
Ceftriaxone—Haemorrhage—Doxorubicin—thyroid cancer	0.00158	0.00178	CcSEcCtD
Ceftriaxone—GLUL—thyroid gland—thyroid cancer	0.00154	0.0891	CbGeAlD
Ceftriaxone—Chills—Epirubicin—thyroid cancer	0.00153	0.00172	CcSEcCtD
Ceftriaxone—Erythema multiforme—Doxorubicin—thyroid cancer	0.00149	0.00168	CcSEcCtD
Ceftriaxone—Flushing—Doxorubicin—thyroid cancer	0.00147	0.00165	CcSEcCtD
Ceftriaxone—Flatulence—Epirubicin—thyroid cancer	0.00147	0.00165	CcSEcCtD
Ceftriaxone—Dysgeusia—Epirubicin—thyroid cancer	0.00146	0.00164	CcSEcCtD
Ceftriaxone—Chills—Doxorubicin—thyroid cancer	0.00142	0.00159	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Epirubicin—thyroid cancer	0.00138	0.00155	CcSEcCtD
Ceftriaxone—Anaemia—Epirubicin—thyroid cancer	0.00137	0.00155	CcSEcCtD
Ceftriaxone—Agitation—Epirubicin—thyroid cancer	0.00137	0.00154	CcSEcCtD
Ceftriaxone—GLUL—head—thyroid cancer	0.00136	0.0791	CbGeAlD
Ceftriaxone—Flatulence—Doxorubicin—thyroid cancer	0.00136	0.00152	CcSEcCtD
Ceftriaxone—Dysgeusia—Doxorubicin—thyroid cancer	0.00135	0.00152	CcSEcCtD
Ceftriaxone—Malaise—Epirubicin—thyroid cancer	0.00134	0.00151	CcSEcCtD
Ceftriaxone—Leukopenia—Epirubicin—thyroid cancer	0.00133	0.0015	CcSEcCtD
Ceftriaxone—Palpitations—Epirubicin—thyroid cancer	0.00131	0.00148	CcSEcCtD
Ceftriaxone—SLC15A2—saliva-secreting gland—thyroid cancer	0.0013	0.0755	CbGeAlD
Ceftriaxone—Convulsion—Epirubicin—thyroid cancer	0.00129	0.00145	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Doxorubicin—thyroid cancer	0.00128	0.00144	CcSEcCtD
Ceftriaxone—Anaemia—Doxorubicin—thyroid cancer	0.00127	0.00143	CcSEcCtD
Ceftriaxone—Agitation—Doxorubicin—thyroid cancer	0.00126	0.00142	CcSEcCtD
Ceftriaxone—Discomfort—Epirubicin—thyroid cancer	0.00125	0.00141	CcSEcCtD
Ceftriaxone—Malaise—Doxorubicin—thyroid cancer	0.00124	0.0014	CcSEcCtD
Ceftriaxone—Leukopenia—Doxorubicin—thyroid cancer	0.00123	0.00138	CcSEcCtD
Ceftriaxone—Palpitations—Doxorubicin—thyroid cancer	0.00122	0.00137	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Epirubicin—thyroid cancer	0.00121	0.00136	CcSEcCtD
Ceftriaxone—Oedema—Epirubicin—thyroid cancer	0.00121	0.00136	CcSEcCtD
Ceftriaxone—Infection—Epirubicin—thyroid cancer	0.00121	0.00136	CcSEcCtD
Ceftriaxone—Convulsion—Doxorubicin—thyroid cancer	0.00119	0.00134	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Epirubicin—thyroid cancer	0.00119	0.00134	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Epirubicin—thyroid cancer	0.00117	0.00132	CcSEcCtD
Ceftriaxone—Discomfort—Doxorubicin—thyroid cancer	0.00116	0.0013	CcSEcCtD
Ceftriaxone—Oedema—Doxorubicin—thyroid cancer	0.00112	0.00126	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00112	0.00126	CcSEcCtD
Ceftriaxone—Infection—Doxorubicin—thyroid cancer	0.00112	0.00125	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Doxorubicin—thyroid cancer	0.0011	0.00124	CcSEcCtD
Ceftriaxone—Paraesthesia—Epirubicin—thyroid cancer	0.00109	0.00123	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00109	0.00122	CcSEcCtD
Ceftriaxone—Dyspepsia—Epirubicin—thyroid cancer	0.00107	0.0012	CcSEcCtD
Ceftriaxone—Pain—Epirubicin—thyroid cancer	0.00104	0.00117	CcSEcCtD
Ceftriaxone—Paraesthesia—Doxorubicin—thyroid cancer	0.00101	0.00113	CcSEcCtD
Ceftriaxone—SLC15A2—trachea—thyroid cancer	0.001	0.0582	CbGeAlD
Ceftriaxone—Feeling abnormal—Epirubicin—thyroid cancer	0.001	0.00112	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000993	0.00112	CcSEcCtD
Ceftriaxone—Dyspepsia—Doxorubicin—thyroid cancer	0.000989	0.00111	CcSEcCtD
Ceftriaxone—Urticaria—Epirubicin—thyroid cancer	0.000964	0.00108	CcSEcCtD
Ceftriaxone—Pain—Doxorubicin—thyroid cancer	0.00096	0.00108	CcSEcCtD
Ceftriaxone—Abdominal pain—Epirubicin—thyroid cancer	0.00096	0.00108	CcSEcCtD
Ceftriaxone—Body temperature increased—Epirubicin—thyroid cancer	0.00096	0.00108	CcSEcCtD
Ceftriaxone—GLUL—lymph node—thyroid cancer	0.000954	0.0554	CbGeAlD
Ceftriaxone—Feeling abnormal—Doxorubicin—thyroid cancer	0.000926	0.00104	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000918	0.00103	CcSEcCtD
Ceftriaxone—Hypersensitivity—Epirubicin—thyroid cancer	0.000894	0.00101	CcSEcCtD
Ceftriaxone—Urticaria—Doxorubicin—thyroid cancer	0.000892	0.001	CcSEcCtD
Ceftriaxone—Abdominal pain—Doxorubicin—thyroid cancer	0.000888	0.000998	CcSEcCtD
Ceftriaxone—Body temperature increased—Doxorubicin—thyroid cancer	0.000888	0.000998	CcSEcCtD
Ceftriaxone—Pruritus—Epirubicin—thyroid cancer	0.000859	0.000966	CcSEcCtD
Ceftriaxone—Diarrhoea—Epirubicin—thyroid cancer	0.000831	0.000934	CcSEcCtD
Ceftriaxone—Hypersensitivity—Doxorubicin—thyroid cancer	0.000828	0.00093	CcSEcCtD
Ceftriaxone—SLC22A8—head—thyroid cancer	0.00081	0.047	CbGeAlD
Ceftriaxone—Dizziness—Epirubicin—thyroid cancer	0.000803	0.000902	CcSEcCtD
Ceftriaxone—Pruritus—Doxorubicin—thyroid cancer	0.000795	0.000893	CcSEcCtD
Ceftriaxone—SLC15A2—thyroid gland—thyroid cancer	0.000793	0.0461	CbGeAlD
Ceftriaxone—Vomiting—Epirubicin—thyroid cancer	0.000772	0.000868	CcSEcCtD
Ceftriaxone—Diarrhoea—Doxorubicin—thyroid cancer	0.000768	0.000864	CcSEcCtD
Ceftriaxone—Rash—Epirubicin—thyroid cancer	0.000765	0.00086	CcSEcCtD
Ceftriaxone—Dermatitis—Epirubicin—thyroid cancer	0.000765	0.00086	CcSEcCtD
Ceftriaxone—Headache—Epirubicin—thyroid cancer	0.00076	0.000855	CcSEcCtD
Ceftriaxone—Dizziness—Doxorubicin—thyroid cancer	0.000743	0.000835	CcSEcCtD
Ceftriaxone—Nausea—Epirubicin—thyroid cancer	0.000721	0.000811	CcSEcCtD
Ceftriaxone—Vomiting—Doxorubicin—thyroid cancer	0.000714	0.000803	CcSEcCtD
Ceftriaxone—Rash—Doxorubicin—thyroid cancer	0.000708	0.000796	CcSEcCtD
Ceftriaxone—Dermatitis—Doxorubicin—thyroid cancer	0.000708	0.000795	CcSEcCtD
Ceftriaxone—SLC15A2—head—thyroid cancer	0.000704	0.0409	CbGeAlD
Ceftriaxone—Headache—Doxorubicin—thyroid cancer	0.000704	0.000791	CcSEcCtD
Ceftriaxone—Nausea—Doxorubicin—thyroid cancer	0.000667	0.00075	CcSEcCtD
Ceftriaxone—ALB—lymph node—thyroid cancer	0.000591	0.0343	CbGeAlD
Ceftriaxone—SLC15A2—lymph node—thyroid cancer	0.000493	0.0286	CbGeAlD
